News | September 22, 2009

Philips, Maquet Integrate Surgical Table, Cardiovascular X-Ray System

September 22, 2009 - At the Transcatheter Cardiovascular Therapeutics (TCT) annual meeting Royal Philips Electronics today announced that it will integrate the MAQUET ‘Magnus’ surgical table with Philips’ cardiovascular X-ray systems to create an efficient ‘hybrid operating room’ environment for a full range of minimally-invasive and open surgical procedures.

Worldwide, there has been a shift away from open surgical procedures as hospitals increasingly move towards more same-day and minimally invasive surgery. As a result, over half of patients leave hospital on the same day as their operation. Catheter-based cardiac treatments have also seen a large rise in comparison with open vascular procedures. As a result, hospitals today require rooms for minimally invasive procedures that are flexible and easily adaptable, and are able to accommodate the full range of current and future surgical technologies.

The solution provided by Philips and MAQUET will offer a cost-effective response to this changing healthcare landscape by optimizing workflow and simplifying the room planning and installation process. The tailored, simplified work environment will help increase the efficiency of procedures and decrease the amount of time that the patient spends in hospital.

“As a global leader in providing X-ray solutions for minimally invasive cardiovascular procedures, we work closely with our customers to listen to and act on their feedback. One message that came back strongly was the need for hybrid operating rooms that offer greater flexibility,” said Bert van Meurs, senior vice president of Cardiovascular X-ray at Philips Healthcare. “By integrating MAQUET’s Magnus table we can allow both minimally invasive procedures and open surgery to take place in a single space, simplifying the clinicians’ work environment.”

At TCT Philips also unveiled the ‘3D Heart Navigator’ interventional tool, which combines 3D CT images of a patients’ cardiac anatomy captured before a procedure into a single image with an overlay of the live X-ray fluoroscopy information. Clinicians attending TCT will be able to view a percutaneous aortic valve device implantation procedure using the 3D Heart Navigator solution that will be broadcast live from Catharina Hospital, Eindhoven, the Netherlands.

“The combined emergence of transcatheter valves and sophisticated interventional tools like Philips’ 3D Heart Navigator means that we’re able to have a major positive impact on the lives of a group of patients who we would’ve previously been unable to help,” commented Dr. J.J. Koolen, head of the department of cardiology, Catharina Hospital. “Replacing a valve in a beating heart is a very challenging procedure. By combining static 3D images with the live 2D image we get a much better understanding of the patient’s anatomy, helping us to achieve the best clinical outcome.”

The solution combining Philips’ Allura interventional X-ray solutions and MAQUET’s Magnus OR table, as well as the Philips 3D Heart Navigator Tool, are scheduled for commercial release in 2010. The live procedure from Catharina Hospital will be presented at 9:30 a.m. PDT, Thursday, Sept. 24.

For more information: www.medical.philips.com

Related Content

Biotronik Announces U.S. Launch of Edora HF-T QP CRT Pacemaker
Technology | Cardiac Resynchronization Therapy Devices (CRT)| August 21, 2017
Biotronik announced U.S. Food and Drug Administration (FDA) approval and commercial availability of Edora HF-T QP, an...
Houston Methodist Hospital Enters Multi-Year Technology and Research Agreement With Siemens Healthineers
News | Cardiac Imaging| August 17, 2017
Houston Methodist Hospital and Siemens Healthineers have entered into a multi-year agreement to bring cutting-edge...
The FDA is concerned about cybersecurity of ICDs and cyber security of other medical devices.
Feature | Cybersecurity| August 16, 2017 | Dave Fornell
There is growing concern among patients and regulators that medical devices, especially implantable electrophysiology
Bivalirudin exhibited an improvement in 30-day all-cause mortality when injected post PCI.
News | Antiplatelet and Anticoagulation Therapies| August 16, 2017
August 16, 2017 — A study has examined the efficacies of various post-percutaneous coronary intervention (PCI) bivali
CMS considers eliminating cardiac bundled payments.
Feature | Business| August 16, 2017 | Dave Fornell
August 16, 2017 — The Centers for Medicare and Medicaid Services (CMS) announced a proposed rule to reduce the number
News | Drug-Eluting Balloons| August 15, 2017
Surmodics Inc. announced receipt of an investigational device exemption (IDE) from the U.S. Food and Drug...
The Vascular Dynamics MobiusHD device enhances the carotid baroreceptors to reduce resistant hypertension.
News | Hypertension| August 15, 2017
Aug. 15, 2017 — The U.S. Food and Drug Administration (FDA) has approved the Vascular Dynamics Inc.
Four Blue Cross Blue Shield Companies Issue Positive Medical Policies on HeartFlow FFRct Analysis
News | FFR Catheters| August 09, 2017
HeartFlow Inc. announced that four Blue Cross Blue Shield companies have each issued a positive medical policy for the...
Ra Medical Systems Granted Broad Patent for DABRA Catheter
News | Peripheral Artery Disease (PAD)| August 09, 2017
August 9, 2017 — Ra Medical Systems announced that the United States Patent and Trademark Office (USPTO) has granted
Overlay Init